Predict your next investment

Khondrion company logo
HEALTHCARE | Pharmaceuticals / Drugs
khondrion.com

See what CB Insights has to offer

Stage

Grant | Alive

About Khondrion

Khondrion is a clinical-stage pharmaceutical company focusing on developing small-molecule therapeutics for mitochondrial diseases.

Khondrion Headquarter Location

Philips van Leydenlaan 15

Nijmegen, 6525,

Netherlands

+31 243610639

Latest Khondrion News

Khondrion heading for pivotal trial as mitochondrial disease competition mounts

Oct 14, 2021

Oct. 13, 2021 Mitochondrial disease, where the tiny energy factories in cells aren’t functioning properly, can have devastating and sometimes fatal consequences. As there are no approved treatments, patients rely on strategies such as strict diets and conserving energy to try and control symptoms that can affect organs including the brain, kidneys, muscles, pancreas and heart. Netherlands-based biotech Khondrion BV is one of a group of companies that is making progress against this group of rare inherited conditions that affects around one in every 4,000 people.

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Khondrion Patents

Khondrion has filed 5 patents.

The 3 most popular patent topics include:

  • Rare diseases
  • Chronic fatigue syndrome
  • Neurological disorders
patents chart

Application Date

Grant Date

Title

Related Topics

Status

10/7/2016

10/27/2020

Rare diseases, Human proteins, Cellular respiration, Proteins, Autosomal recessive disorders

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

10/7/2016

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Grant Date

10/27/2020

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Rare diseases, Human proteins, Cellular respiration, Proteins, Autosomal recessive disorders

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Khondrion Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Khondrion Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.